Peptonic offers products for intimate self-care. The portfolio is sold under the VagiVital brand and offers women solutions to independently diagnose and treat medical conditions in the vagina.
Our flagship brand for medical consumers is VagiVital. VagiVital’s vision is to enable all women to enjoy and have an inspiring life despite vaginal issues, such as vaginal atrophy. Our goal is to solve any vaginal problem women may have with clinically proven self-care.
The vision is to enable women to live the life they desire by offering innovative, clinically proven, high-quality, and accessible intimate care products and services, which help relieve healthcare systems worldwide.
The vision is to enable women to live the life they desire by offering innovative, clinically proven, high-quality, and accessible intimate care products and services, which help relieve healthcare systems worldwide.
For medical conditions in intimate health, there are prescribing products and self-care products. Peptonic's goal is to position the Company between these, with clinically proven intimate self-care and be a leading player with a clear position and profiling. The company's ambition is to achieve this by developing and acquiring an innovative product portfolio that enables the female consumer to manage their intimate health from diagnosis to treatment and to prevent diseases.
VagiVital VS self-test can diagnose symptoms of bacterial vaginosis and vaginal fungal infections with 92 percent accuracy. The test is carried out on vaginal fluid and indicates the response within 30 seconds by color change. The result is based on a combined indication of pH level and buffer capacity in the discharge. The two-step mechanism is patented and allows VagiVital VS to have much higher precision compared to conventional pH tests. The advantage over the tests submitted to a laboratory is that the result is obtained immediately with VagiVital VS.
VagiVital AL is a self-test that makes it possible to detect leaking amniotic fluid during pregnancy in the event of perceived unidentified fluid leakage. The self-test consists of a panty liner with a patented biofilm on the surface of the panty liner. When used, the panty liner is placed in the panties and should remain there until the pregnant woman experiences moisture. Then the panty liner is taken out. 15 minutes after the panty liner is removed, the result can be read, VagiVital AL distinguishes between amniotic leakage and urine with 97 percent accuracy. The high precision comes from a combination of measuring pH and binding amongst other ammonium to receptors in the biofilm on the pantyliner. VagiVital AL is patented.
VagiVital AktivGel is a hormone-free treatment for symptoms linked to vaginal atrophy such as pain during intercourse, burning, itching and dryness. The product offers an alternative for women who cannot or should not use hormone-based drugs and has a positive clinically proven effect according to the Company's studies from 2017 and 2020. The results of the studies showed severe relief of symptoms such as vaginal dryness, itching and sexual intercourse pain. In addition, vaginal pH is normalized as a result of treatment with VagiVital AktivGel.
Perfumed products and soaps risk drying out the vaginal mucosa and can lead to vaginal atrophy and/or vaginal infections such as bacterial vaginosis. VagiVital Moisturizing V Cleanser is based on VagiVital AktivGel in combination with a botanical oil. The product allows cleaning of both water- and oil-soluble impurities while moisturizing unlike an oil-based intimate wash.
